Julie Jeschke
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Julie Jeschke has a total of 16 co-authors. Here are the top co-authors by number of shared publications:
Alex N. Beckett
17 shared publications- Ashley Chabot
St. Jude Children’s Research Hospital 6 Department of Surgery Memphis, Tennessee
17 shared publications - Carla O’REilly
St. Jude Children’s Research Hospital 1 Department of Bone Marrow Transplantation and Cellular Therapy Memphis, Tennessee
17 shared publications - Christopher DeRenzo
Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children’s Research Hospital, Memphis, TN
17 shared publications - Giedre Krenciute
Department of Bone Marrow Transplantation and Cellular Therapy, St. Jude Children's Research Hospital, Memphis, TN, USA
17 shared publications - Haley Houke
St. Jude Children’s Research Hospital 1 Department of Bone Marrow Transplantation and Cellular Therapy Memphis, Tennessee
17 shared publications
Latest Publications
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 5 from LRRC15-CAR T Cells for the Treatment of Osteosarcoma
LRRC15-CAR T cell phenotypes after repeat stimulation with OS152 osteosarcoma cells
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 5 from LRRC15-CAR T Cells for the Treatment of Osteosarcoma
LRRC15-CAR T cell phenotypes after repeat stimulation with OS152 osteosarcoma cells
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 1 from LRRC15-CAR T Cells for the Treatment of Osteosarcoma
Lrrc15 expression in normal murine tissues by ISH detection
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 1 from LRRC15-CAR T Cells for the Treatment of Osteosarcoma
Lrrc15 expression in normal murine tissues by ISH detection
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Table 2 from LRRC15-CAR T Cells for the Treatment of Osteosarcoma
Evaluation of murine tissues post T cell infusion
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Table 2 from LRRC15-CAR T Cells for the Treatment of Osteosarcoma
Evaluation of murine tissues post T cell infusion
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 4 from LRRC15-CAR T Cells for the Treatment of Osteosarcoma
LRRC15-CAR T cell phenotypes after repeat stimulation with LM7 osteosarcoma cells
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 4 from LRRC15-CAR T Cells for the Treatment of Osteosarcoma
LRRC15-CAR T cell phenotypes after repeat stimulation with LM7 osteosarcoma cells
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 1 from LRRC15-CAR T Cells for the Treatment of Osteosarcoma
LRRC15 expression in human melanoma and melanocyte samples
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 1 from LRRC15-CAR T Cells for the Treatment of Osteosarcoma
LRRC15 expression in human melanoma and melanocyte samples
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 7 from LRRC15-CAR T Cells for the Treatment of Osteosarcoma
LRRC15-CAR T cells exhibit transient antitumor activity and enhance survival in a bulky orthotopic limb osteosarcoma model
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 7 from LRRC15-CAR T Cells for the Treatment of Osteosarcoma
LRRC15-CAR T cells exhibit transient antitumor activity and enhance survival in a bulky orthotopic limb osteosarcoma model
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 12 from LRRC15-CAR T Cells for the Treatment of Osteosarcoma
LRRC15-CAR T cells do not cause weight loss in tumor bearing mice
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 12 from LRRC15-CAR T Cells for the Treatment of Osteosarcoma
LRRC15-CAR T cells do not cause weight loss in tumor bearing mice
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 10 from LRRC15-CAR T Cells for the Treatment of Osteosarcoma
Tumors from mice with progressive intravenous LM7 lung osteosarcoma have limited LRRC15 expression after treatment with LRRC15-CAR T cells
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 10 from LRRC15-CAR T Cells for the Treatment of Osteosarcoma
Tumors from mice with progressive intravenous LM7 lung osteosarcoma have limited LRRC15 expression after treatment with LRRC15-CAR T cells
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 13 from LRRC15-CAR T Cells for the Treatment of Osteosarcoma
Pre-infusion healthy donor T cell characteristics for in vivo studies
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 13 from LRRC15-CAR T Cells for the Treatment of Osteosarcoma
Pre-infusion healthy donor T cell characteristics for in vivo studies
- Open Access
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Supplementary Figure 8 from LRRC15-CAR T Cells for the Treatment of Osteosarcoma
LRRC15-CAR T cell persistence in the OS152 orthotopic osteosarcoma model
- 17 June 2026
- Published by American Association for Cancer Research (AACR)
Open AccessSupplementary Figure 8 from LRRC15-CAR T Cells for the Treatment of Osteosarcoma
LRRC15-CAR T cell persistence in the OS152 orthotopic osteosarcoma model